RecruitingPhase 3NCT07028853This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Sponsor: PfizerDallas, TX · +124 more sites
RecruitingPhase 3NCT03678025Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerSponsor: SWOG Cancer Research NetworkConroe, TX · Dallas, TX · +331 more sites
RecruitingPhase 2NCT06632977Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialSponsor: Alliance for Clinical Trials in OncologyDallas, TX · +105 more sites
RecruitingPhase 3NCT04423211Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingSponsor: ECOG-ACRIN Cancer Research GroupDallas, TX · +338 more sites